Pfizer's second-quarter closed and they reported a profit of 18.98 billion. That is just from the second quarter. This is, of course, a result of the vaccine.
However, their drug Vyndaquel (used for cardiomyopathy) profits rose by 77% and their drug Eliquis (used for blood clots) rose by 13%.
If you are too stupid to make the connection with the two other products, the rise in profit is due to the vaccine causing heart and blood clot issues.